Evidence map›Paper›PMID 33059294›Full record

ArticleSeminars in arthritis and rheumatism2020

Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members.

Achille Marino, Micol Romano, Maurizio Gattinara, Rolando Cimaz

Abstract readLetterComment
In one paragraph

Article in Seminars in arthritis and rheumatism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Optimal biologics for juvenile idiopathic arthritis in an infection with SARS-CoV-2 α-variant.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Achille MarinoDepartment of Pediatrics, Desio Hospital, ASST Monza, Via Mazzini 1, 20832 Desio (MB), Italy. Electronic address: achillemarino6@gmail.com.
Micol RomanoASST G.Pini-CTO, Via Gaetano Pini 9, 20122 Milan, Italy.
Maurizio GattinaraASST G.Pini-CTO, Via Gaetano Pini 9, 20122 Milan, Italy.
Rolando CimazASST G.Pini-CTO, Via Gaetano Pini 9, 20122 Milan, Italy; Department of Clinical Sciences and Community Health, and Research Center for Adult and Pediatric Rheumatic Diseases, University of Milan, Via della Commenda 19, 20122 Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antirheumatic AgentsArthritis, JuvenileBiological ProductsCOVID-19Rheumatic DiseasesAdultChildFamilyHumansIncidencePandemicsSARS-CoV-2Tumor Necrosis Factor InhibitorsAntirheumatic AgentsBiological ProductsTumor Necrosis Factor InhibitorsCOVID-19Juvenile idiopathic arthritisRheumatic diseaseSARS-CoV-2TNF inhibitor

Identifiers

PMID33059294
PMCPMC7531912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.